Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rosen

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flowJames P Stevenson, Mark Rosen, Weijing Sun, et al.
Seminars in Radiation Oncology|September 8, 2023
The Importance of Quality Assurance in Radiation Oncology Clinical TrialsThomas J FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast CancerAmy S Clark, Nicholas P McAndrew, Andrea Troxel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.
Radiology|April 1, 2009
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic studyJeffrey C Weinreb, Jeffrey D Blume, Fergus V Coakley, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 20, 2018
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trialsAmita Shukla-Dave, Nancy A Obuchowski, Thomas L Chenevert, et al.
Journal of the American Medical Informatics Association : JAMIA|February 12, 2021
Quantification of abdominal fat from computed tomography using deep learning and its association with electronic health records in an academic biobankMatthew T MacLean, Qasim Jehangir, Marijana Vujkovic, et al.
Frontiers in Oncology|February 13, 2023
Quality improvements in radiation oncology clinical trialsKoren Smith, Kenneth Ulin, Michael Knopp, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flowJames P Stevenson, Mark Rosen, Weijing Sun, et al.
Seminars in Radiation Oncology|September 8, 2023
The Importance of Quality Assurance in Radiation Oncology Clinical TrialsThomas J FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast CancerAmy S Clark, Nicholas P McAndrew, Andrea Troxel, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2021
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant RecipientsLauren N Krumeich, Jenna Mancinelli, Andy Cucchiara, et al.
Radiology|April 1, 2009
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic studyJeffrey C Weinreb, Jeffrey D Blume, Fergus V Coakley, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 20, 2018
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trialsAmita Shukla-Dave, Nancy A Obuchowski, Thomas L Chenevert, et al.
Journal of the American Medical Informatics Association : JAMIA|February 12, 2021
Quantification of abdominal fat from computed tomography using deep learning and its association with electronic health records in an academic biobankMatthew T MacLean, Qasim Jehangir, Marijana Vujkovic, et al.
Frontiers in Oncology|February 13, 2023
Quality improvements in radiation oncology clinical trialsKoren Smith, Kenneth Ulin, Michael Knopp, et al.
Pageof 9